Also from this source

You just read:

Final Results of the Phase I/II Clinical Study of BST-236 in Acute Leukemia Patients will be Presented at the 2017 Annual ASH Meeting

News provided by

BioSight, Ltd

Dec 04, 2017, 07:00 EST